Ghose T, Guclu A, Faulkner J, Tal J
J Natl Cancer Inst. 1977 Mar;58(3):693-700. doi: 10.1093/jnci/58.3.693.
Three of more than 50 batches of rabbit antisera raised against the mouse EL 4 lymphoma could inhibit the growth of the tumor in the syngeneic C57BL/6J mice either after exposure of the tumor cells to the antitumor globulin (ATG) in vitro or after the administration of ATG in mice preinoculated with various numbers of EL 4 cells, even though the ATG was not cytotoxic to the tumor cells in the presence of complement. The outcome of immunotherapy with ATG in tumor-bearing C57BL/6J mice depended on the tumor load, the interval between tumor inoculation and the institution of therapy, the total dose, and the schedule of administration of ATG. Complete tumor suppression could be obtained in a proportion of mice preinoculated with 10(5) EL 4 cells, i.e., 10(4) times more than the minimum number of EL 4 cells necessary for 100% tumor takes. Whole-body irradiation (400 rads) or complement depletion of tumor host by cobra venom factor had no effect on tumor suppression by ATG. No evidence of immunity against the EL 4 lymphoma could be detected in EL 4-bearing mice that survived after serotherapy. Anti-EL 4 sera raised in goats and goat and rabbit antisera raised against a lymphoma in the AKR mice have, so far, failed to show any tumor inhibition.
在针对小鼠EL 4淋巴瘤制备的50多批兔抗血清中,有三批在体外将肿瘤细胞暴露于抗肿瘤球蛋白(ATG)后,或在给预先接种了不同数量EL 4细胞的小鼠注射ATG后,能够抑制同基因C57BL/6J小鼠体内肿瘤的生长,尽管在有补体存在的情况下,ATG对肿瘤细胞没有细胞毒性。在荷瘤C57BL/6J小鼠中,用ATG进行免疫治疗的结果取决于肿瘤负荷、肿瘤接种与治疗开始之间的间隔、ATG的总剂量以及给药方案。在一部分预先接种10(5)个EL 4细胞的小鼠中可实现肿瘤的完全抑制,即比100%肿瘤接种所需的EL 4细胞最小数量多10(4)倍。全身照射(400拉德)或用眼镜蛇毒因子使肿瘤宿主的补体耗竭,对ATG的肿瘤抑制作用没有影响。在血清治疗后存活的荷EL 4淋巴瘤小鼠中,未检测到针对EL 4淋巴瘤的免疫证据。到目前为止,在山羊中制备的抗EL 4血清以及针对AKR小鼠淋巴瘤制备的山羊和兔抗血清均未显示出任何肿瘤抑制作用。